There is an exception to sections 201(ff)(3)(B)(i) and (ii) if the substance was "marketed as" a dietary supplement or as a conventional food before the drug was approved or before the new drug investigations were authorized, as applicable. However, based on available evidence, FDA has concluded that this is not the case for THC or CBD. For more information on this provision, including an explanation of the phrase "marketed as," see Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.
Kalapa Clinic está compuesta por un equipo multidisciplinar de doctores, psicólogos e investigadores, unidos por la sincera opinión de que la Cannabis Sativa L tiene innumerables posibles usos terapeúticos . Apoyamos el derecho inalienable a decidir, tanto el paciente como el facultativo,a la hora de prescribir o realizar un seguimiento en tratamientos con cannabinoides.